help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLoud, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLoud, T. C.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 408-409, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.2506004


Editorial

Role of High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis

The Final Word?

Theresa C. McLoud, M.D.

Massachusetts General Hospital, Boston, Massachusetts

The information available from high-resolution computed tomography (HRCT) scans of the lung has changed our approach to the assessment of chronic infiltrative lung disease. Improved scanner resolution has provided lung parenchymal imaging at the level of the secondary pulmonary lobular level. Such images permit ready identification of the distribution and the types of opacities and other abnormalities identified in chronic interstitial disease, all of which play an important role in diagnosis.

Since the advent of HRCT in the late 1980s, many studies have confirmed improved diagnostic accuracy as compared with standard radiographs. The majority of patients suspected of having a chronic infiltrative process in the lungs now undergo an HRCT during their initial investigation. It has been suggested that, in some cases, the imaging data combined with clinical information is adequate for diagnosis, and biopsy may not be required. Such "diagnostic" HRCT studies may occur in such entities as idiopathic pulmonary fibrosis (IPF), lymphangitic spread of carcinoma, and sarcoidosis.

Regarding IPF, identification of usual interstitial pneumonia (UIP) on surgical lung biopsy has been considered the gold standard for diagnosis (1). However, when typical clinical and high-resolution HRCT features are present and assessed by expert clinicians and radiologists, the features may allow a confident diagnosis in more than 50% of cases and eliminate the need for surgical lung biopsy (2). The article in this issue (pp. 488–493) by Lynch and coworkers from the IPF Study Group (3) addresses additional aspects of the important role of HRCT in the diagnosis and follow-up of patients with IPF. The authors specifically focus on the HRCT features of patients with mild to moderate physiologic impairment, the reliability of HRCT interpretation among radiologists both in academic and community settings, and the usefulness of HRCT findings as predictors of mortality (4, 5). This study is unique because of the size of the cohort (i.e., 315 patients with IPF who were enrolled in a randomized, controlled study evaluating the efficacy of IFN-{gamma}1b treatment).

One of the important findings of this study was the concordance between the interpretations of the study-site radiologists, which included radiologists from both academic and community centers, and a core group of expert thoracic radiologists. Concordance regarding the diagnosis of IPF occurred in 86% of the cases. Over the past decade there has been widespread dissemination of knowledge concerning the HRCT features of the infiltrative lung diseases. It is common practice for thinly collimated HRCT images to be included in every thoracic CT study. The advent of multidetector helical CT now permits generation of thin-section images retrospectively from an acquired volumetric set of data. Competent interpretation of HRCT is no longer limited to experts. Identification of the common features of UIP or IPF, such as honeycombing, reticulation, and traction bronchiectasis, is now in the standard skill set of most radiologists.

One of the surprising findings of this study was the poor agreement among core radiologists regarding the presence or absence of honeycombing, a very critical feature in the diagnosis of IPF. We agree with the authors that the development of a set of standardized CT images illustrating various HRCT features in interstitial disease, similar to the standard radiographs for International Labour Organization (ILO) classification of the pneumoconioses, is sorely needed. Such standardized images may help reduce discrepancies among readers. Advances in computerized automated methods of disease characterization and quantification may be helpful, as the authors have suggested (6, 7).

A consensus diagnosis of IPF by the core radiologists was achieved in 88% of patients who had a histologic diagnosis of UIP before study entry. The typical UIP patterns seen on HRCT thus predict the underlying UIP pathology. However, one of the weaknesses in the design of this study was the lack of centralized and standardized pathologic readings of surgical lung biopsies by consensus of an expert panel of pathologists. The reliability of the histologic diagnosis in this cohort has therefore not been validated. This study also confirms the work of others that the diffusing capacity of carbon monoxide and the HRCT fibrosis score (a combination of the severity of reticulation and honeycombing) are two of the most accurate predictors of mortality (8).

The findings in this study certainly support the premise that HRCT is an important part of the evaluation of patients with suspected IPF. The data would support the conclusion that competent interpretation of HRCT findings in infiltrative lung disease can be accomplished by radiologists at regional medical centers. The reliability of the radiologic diagnosis, however, would be greatly enhanced by the development of standardized definitions and standardized images of HRCT findings. There also appears to be convincing evidence that surgical biopsy is not required in patients with classic features of reticulation and honeycombing, which are diagnostic of IPF. HRCT can be considered another important and independent predictor of survival.

FOOTNOTES

Conflict of Interest Statement: T.C.M. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199–203.
  2. Schwartz DA, Van Fossen DS, Davis CS, Helmers RA, Dayton CS, Burmeister LF, Hunninghake GW. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:444–449.[Abstract]
  3. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488–493.[Abstract/Free Full Text]
  4. Gay SE, Kazerooni EA, Toews GB, Lynch J III, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998;157:1063–1072.[Abstract/Free Full Text]
  5. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis relationships of pulmonary physiology and bronchoalveolar lavage to treatment and prognosis. Am Rev Respir Dis 1981;124:1–8.[Medline]
  6. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899–905.[Abstract/Free Full Text]
  7. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010–1019.[Abstract]
  8. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801–809.[Abstract]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLoud, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLoud, T. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society